Exclusive
Release Date
Pandemic Impact on Clinical Trial Recruitment with Atul Mahableshwarkar, M.D., DFAPA
Are Virtual SIVs the Future?: Interview with Jennifer Brandl
Why every clinical trial needs to consider Middle East and African sites: Interview with Ahmed Hamouda
Increasing Access to People of African Descent in Pharma: Interview with Peju Oshisanya
How Can We Manage the Increasing Complexity of Clinical Trial Protocols? Interview with Ken Getz of Tufts Center for the Study of Drug Development